For the first time, a major trigger in inflammatory bowel disease (IBD) and related conditions has been identified, and existing drugs can stamp it out, in what scientists call a "massive step" in ...

Advanced therapies reduce bowel urgency in nearly half of patients with inflammatory bowel disease, new research finds.

Early and aggressive immunosuppressive therapy with tumor necrosis factor (TNF) inhibitors significantly outperformed conventional therapy for patients with newly diagnosed Crohn's disease and should ...

ISM5411 is an oral, PHD 1/2-specific inhibitor that facilitates the treatment of IBD by inducing the expression of gut barrier protective genes. ISM5411 is Insilico Medicine’s fifth AI-driven drug ...

June 6, 2024 – Scientists in the United Kingdom have pinpointed genetic factors that appear to drive inflammatory bowel disease, and laboratory experiments using existing drugs used for other ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...